Summary & Overview
HCPCS Level II J1230: Methadone HCl Injection, up to 10 mg
HCPCS Level II code J1230 denotes an injection of methadone hydrochloride, up to 10 mg. The code matters nationwide because methadone injections are used in acute pain management and certain medication-assisted treatment settings, and accurate coding affects clinical documentation, payer adjudication, and controlled substance monitoring. This analysis covers major national payers including Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.
Readers will find concise benchmarks and policy context for billing and coverage considerations tied to parenteral methadone. The publication outlines payer coverage patterns, common billing scenarios, and documentation elements relevant to outpatient and facility-based administration. It also provides clinical context on the service type and typical sites of service where J1230 is applied, and notes where input data was unavailable. The goal is to inform billing staff, compliance officers, and revenue cycle teams about the code’s purpose, common service settings, and the scope of payers addressed in national comparisons.
Billing Code Overview
HCPCS Level II code J1230 represents an injection of methadone hydrochloride, up to 10 mg per administration. This code is used to report parenteral administration of methadone for clinical indications requiring controlled opioid therapy.
-
Service type: Injectable opioid agonist therapy
-
Typical site of service: Outpatient clinics, ambulatory infusion centers, behavioral health treatment facilities, and emergency departments where short-acting parenteral opioid administration is provided.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult enrolled in an outpatient medication-assisted treatment (MAT) program for opioid use disorder who presents to a clinic for directly observed therapy. The patient has a history of opioid dependence and is receiving methadone as part of a structured maintenance plan. At arrival, nursing staff verify identity, perform brief vitals and withdrawal assessment, review the current treatment plan and medication dose, and confirm consent for supervised administration. The clinic prepares a single-dose injectable methadone formulation labeled as J1230 (injection, methadone HCl, up to 10 mg). A licensed clinician or authorized dispenser administers the intramuscular or subcutaneous injection per facility protocol, documents lot number and dose on the medication administration record, observes the patient for adverse reaction for the required monitoring period, and records the encounter in the electronic health record. Billing is submitted using J1230 with applicable modifiers to indicate circumstances such as professional component, unusual services, or patient status changes. Typical sites of service include outpatient opioid treatment programs, ambulatory clinics, community health centers, and hospital outpatient departments. Typical documentation includes indication (opioid dependence), signed consent for methadone therapy, dosage administered, route, site, lot number, supervising provider, and post-administration observations.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 |